JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
REVIEW
Add like
Add dislike
Add to saved papers

Nutrition of the human fetus during the first trimester--a review.

Placenta 2001 April
In all mammalian species nutrition of the conceptus is initially histiotrophic, with the trophectoderm phagocytosing first oviductal and then uterine secretions. Following implantation and establishment of the chorioallantoic placenta there is a transition to haemotrophic nutrition, with exchange between the maternal and fetal circulations. It has long been assumed that the transition occurs soon after implantation in the human, due to the invasive nature of this process. However, the recent realization that the maternal circulation to the placenta is not fully established until the end of the first trimester casts doubt on the validity of this assumption. There is new evidence that the uterine glands discharge secretions into the intervillous space until at least 8 weeks of pregnancy, and that these are taken up by the syncytiotrophoblast. Also, during early pregnancy selected maternal proteins accumulate within the fluid of the coelomic cavity, from which they may be transported to the fetus by the secondary yolk sac. Histiotrophic nutrition may be advantageous to the fetus during the first trimester as it provides nutrients under a low oxygen concentration, so reducing the risk of free radical mediated damage during the sensitive period of organogenesis. Once this is complete, and fetal oxygen requirements rise, there is a transition to haemotrophic nutrition at the start of the second trimester, when the maternal placental circulation is fully established.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app